Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03730402 · ClinicalTrials.gov registry record · Phase 4
Laparoscopic Assisted Plane Block (LAPB) Trial
A Phase 4 study, sponsored by Santa Barbara Cottage Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT03730402: Clinical Trial Phase 4 study, sponsored by Santa Barbara Cottage Hospital.
NCT03730402 is a Phase 4 study that was terminated before completion, run by Santa Barbara Cottage Hospital. The registered enrollment target is 34 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03730402, a Phase 4 study, was terminated before completion, sponsored by Santa Barbara Cottage Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study attempts to demonstrate improvement in analgesia in a more diverse laparoscopic surgery group with the use of laparoscopic assisted transversus abdominis plane blocks. The investigators will compare bupivacaine (treatment arm 1) versus liposomal bupivacaine (treatment arm 2) versus port site injection of local anesthesia with injection of saline placebo (control). The hypothesis is that liposomal bupivacaine will result in improved analgesia when compared to bupivacaine LAPB and control. The investigators further hypothesize that bupivacaine LAPB will be more effective than the control.
Primary Outcome
post-operative narcotic usage expressed in morphine equivalents
Interventions
- DRUG Bupivacaine
- DRUG Saline
- DRUG Exparel 266 milligram Per 20 ML Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2021-04-14 |
| Phase | Phase 4 |
Why NCT03730402 stopped before completion
NCT03730402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.
NCT03730402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03730402 about?
NCT03730402 is a clinical study titled "Laparoscopic Assisted Plane Block (LAPB) Trial". This study attempts to demonstrate improvement in analgesia in a more diverse laparoscopic surgery group with the use of laparoscopic assisted transversus abdominis plane blocks. The investigators will compare bupivacaine (treatment arm 1) versus liposomal bupivacaine (treatment arm 2) versus port s...
What is the current status of trial NCT03730402?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2019-02-04. Estimated completion is 2021-04-14.
What interventions are being tested in trial NCT03730402?
The interventions under investigation include: Bupivacaine (DRUG), Saline (DRUG), Exparel 266 milligram Per 20 ML Injection (DRUG).
Who is sponsoring clinical trial NCT03730402?
This trial is sponsored by Santa Barbara Cottage Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03730402's enrollment target sits among peer trials
34 1520th of 2000 higher than 473 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI